google-site-verification: googlec7193c3de77668c9.html

Antibody halts triple-negative breast cancer in preclinical models

[
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with targeted therapies. Even when patients initially respond to treatment, the cancer often returns and is more resistant than before.


Source link

Advertisements

See also  Prostate cancer is the second-leading cancer among men. Here's what to know about it

Check Also

The Pitt is up for 25 Emmys – but the show’s biggest fans are real-life doctors

Doctors we spoke to do point out that each episode of The Pitt brings together …

New US Medicare pricing policies could reshape global pharmaceutical markets

[ Credit: SHVETS production from Pexels A new modeling study published in The Lancet suggests …

Masked antibodies may open intracellular treatment route for Parkinson’s disease

[ Credit: Unsplash/CC0 Public Domain Over the past few decades, antibody-based therapies have revolutionized modern …

Leave a Reply

Available for Amazon Prime